» Authors » S L Beck

S L Beck

Explore the profile of S L Beck including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 217
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Owen K, Beck S, Damment S
Hum Exp Toxicol . 2010 Mar; 29(5):393-407. PMID: 20219844
An extensive toxicology programme on salmeterol hydroxynaphthoate (Serevent), a marketed long-acting beta(2)-adrenoceptor agonist, has been carried out. The studies evaluated both the local (respiratory tract) and systemic tolerance to single...
2.
Mitchell S, Leidy N, Mooney K, Dudley W, Beck S, LaStayo P, et al.
Bone Marrow Transplant . 2009 Sep; 45(4):762-9. PMID: 19784078
This study examined factors accounting for functional performance limitations in 100 long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Functional performance, measured by the SF-36...
3.
Beck S
Reprod Toxicol . 2001 Jan; 15(1):43-8. PMID: 11137377
Reciprocal outcrosses and backcrosses were made between strains of mice with different susceptibilities to valproic acid (VPA) teratogenicity. Relatively resistant C57BL/6J (C) and more susceptible SWV (S) strains of mice...
4.
Lutz J, Beck S
Teratology . 2000 Oct; 62(5):325-31. PMID: 11029150
Background: Cadmium is a well-known animal teratogen. Caffeine is an alkaloid widely consumed by humans. Interactions between teratogens and nonteratogenic doses of other agents are becoming widely studied, as they...
5.
Meek P, Nail L, Barsevick A, Schwartz A, Stephen S, Whitmer K, et al.
Nurs Res . 2000 Aug; 49(4):181-90. PMID: 10929689
Background: Cancer treatment-related fatigue (CRF) is a common side effect of cancer treatment. A problem identified in most reviews of CRF is lack of sound approaches to measurement that are...
6.
Beck S
Cancer Nurs . 2000 Apr; 23(2):91-9; quiz 99-100. PMID: 10763279
Although the knowledge exists to relieve cancer pain, inadequate pain relief persists as an international health problem. The World Health Organization has recommended a threefold strategy to improve cancer pain...
7.
Paros A, Beck S
Teratology . 1999 Dec; 60(6):344-7. PMID: 10590395
The A/WySnBk strain of mice displays 25-35% spontaneous CL(P). Pregnant mice were treated with folinic acid continuously delivered via osmotic minipumps at the rate of 7.6 +/- 0.2 microl/ hr...
8.
Beck S
Reprod Toxicol . 1999 Nov; 13(5):353-60. PMID: 10560583
To ascertain the relative contributions of genotypes of conceptus and dam to developmental toxicity occasioned by valproic acid (VPA), crosses were established between resistant C57BL/6JBk (C, C57) and susceptible SWV/Bk...
9.
Beck S
J Pain Symptom Manage . 1999 Jan; 17(1):16-26. PMID: 9919862
In 1982, the World Health Organization (WHO) identified inadequate relief from cancer pain as an international health problem. WHO recommended that governments develop and implement national policies and programs for...
10.
Nail L, Barsevick A, Meek P, Beck S, Jones L, Walker B, et al.
Oncol Nurs Forum . 1998 Oct; 25(8):1398-403. PMID: 9766293
Purpose/objectives: To describe the process used in proposal development and study implementation for a complex multisite project on cancer treatment-related fatigue (CRF), identify strategies used to manage the project, and...